DLA PIPER LLP (US)

Lobbying for PRELUDE CORPORATION (PRELUDEDX) · Precision cancer diagnostics company.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income · posted Oct 16, 2025

Lobbying activity 2

Health Issues

Improved patient access to cancer screening diagnostics.

Medicare/Medicaid

Policies related to Medicare reimbursement for cancer diagnostics.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.